We previously identified novel C‐terminus RUNX2 mutations in CCD patients and observed RUNX2 overexpression in osteogenic differentiated cMSCs of these CCD patients compared to control cells.23 Here, RUNX2 is linked to cleidocranial dysplasia 1.